Logo image of BIM.PA

BIOMERIEUX (BIM.PA) Stock Fundamental Analysis

EPA:BIM - Euronext Paris - Matif - FR0013280286 - Common Stock - Currency: EUR

117.4  -1.6 (-1.34%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to BIM. BIM was compared to 58 industry peers in the Health Care Equipment & Supplies industry. BIM has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. BIM has a correct valuation and a medium growth rate. This makes BIM very considerable for quality investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

BIM had positive earnings in the past year.
In the past year BIM had a positive cash flow from operations.
BIM had positive earnings in each of the past 5 years.
BIM had a positive operating cash flow in each of the past 5 years.
BIM.PA Yearly Net Income VS EBIT VS OCF VS FCFBIM.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

1.2 Ratios

BIM has a better Return On Assets (7.49%) than 79.31% of its industry peers.
BIM's Return On Equity of 10.28% is fine compared to the rest of the industry. BIM outperforms 74.14% of its industry peers.
Looking at the Return On Invested Capital, with a value of 9.33%, BIM belongs to the top of the industry, outperforming 81.03% of the companies in the same industry.
BIM had an Average Return On Invested Capital over the past 3 years of 10.05%. This is above the industry average of 8.02%.
Industry RankSector Rank
ROA 7.49%
ROE 10.28%
ROIC 9.33%
ROA(3y)7.67%
ROA(5y)9.27%
ROE(3y)10.79%
ROE(5y)13.66%
ROIC(3y)10.05%
ROIC(5y)11.9%
BIM.PA Yearly ROA, ROE, ROICBIM.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

BIM has a better Profit Margin (10.86%) than 72.41% of its industry peers.
BIM's Profit Margin has been stable in the last couple of years.
With a decent Operating Margin value of 14.79%, BIM is doing good in the industry, outperforming 74.14% of the companies in the same industry.
In the last couple of years the Operating Margin of BIM has grown nicely.
With a Gross Margin value of 55.66%, BIM perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
In the last couple of years the Gross Margin of BIM has remained more or less at the same level.
Industry RankSector Rank
OM 14.79%
PM (TTM) 10.86%
GM 55.66%
OM growth 3Y-12.86%
OM growth 5Y2.09%
PM growth 3Y-15.19%
PM growth 5Y1.26%
GM growth 3Y-2.07%
GM growth 5Y0.3%
BIM.PA Yearly Profit, Operating, Gross MarginsBIM.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BIM is still creating some value.
The number of shares outstanding for BIM remains at a similar level compared to 1 year ago.
Compared to 5 years ago, BIM has less shares outstanding
The debt/assets ratio for BIM has been reduced compared to a year ago.
BIM.PA Yearly Shares OutstandingBIM.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
BIM.PA Yearly Total Debt VS Total AssetsBIM.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

An Altman-Z score of 6.80 indicates that BIM is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 6.80, BIM belongs to the top of the industry, outperforming 91.38% of the companies in the same industry.
BIM has a debt to FCF ratio of 1.53. This is a very positive value and a sign of high solvency as it would only need 1.53 years to pay back of all of its debts.
BIM's Debt to FCF ratio of 1.53 is amongst the best of the industry. BIM outperforms 86.21% of its industry peers.
BIM has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
With an excellent Debt to Equity ratio value of 0.08, BIM belongs to the best of the industry, outperforming 84.48% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 1.53
Altman-Z 6.8
ROIC/WACC1.2
WACC7.75%
BIM.PA Yearly LT Debt VS Equity VS FCFBIM.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

A Current Ratio of 2.20 indicates that BIM has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.20, BIM is in the better half of the industry, outperforming 65.52% of the companies in the same industry.
BIM has a Quick Ratio of 1.29. This is a normal value and indicates that BIM is financially healthy and should not expect problems in meeting its short term obligations.
BIM has a better Quick ratio (1.29) than 62.07% of its industry peers.
Industry RankSector Rank
Current Ratio 2.2
Quick Ratio 1.29
BIM.PA Yearly Current Assets VS Current LiabilitesBIM.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

6

3. Growth

3.1 Past

BIM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 21.01%, which is quite impressive.
Measured over the past years, BIM shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.91% on average per year.
Looking at the last year, BIM shows a quite strong growth in Revenue. The Revenue has grown by 8.31% in the last year.
BIM shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.27% yearly.
EPS 1Y (TTM)21.01%
EPS 3Y-8.75%
EPS 5Y10.91%
EPS Q2Q%10.71%
Revenue 1Y (TTM)8.31%
Revenue growth 3Y5.64%
Revenue growth 5Y8.27%
Sales Q2Q%9.1%

3.2 Future

Based on estimates for the next years, BIM will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.37% on average per year.
The Revenue is expected to grow by 6.35% on average over the next years.
EPS Next Y20.14%
EPS Next 2Y16.12%
EPS Next 3Y15.21%
EPS Next 5Y13.37%
Revenue Next Year7.29%
Revenue Next 2Y7.04%
Revenue Next 3Y7.59%
Revenue Next 5Y6.35%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BIM.PA Yearly Revenue VS EstimatesBIM.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B 5B
BIM.PA Yearly EPS VS EstimatesBIM.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 30.41, the valuation of BIM can be described as expensive.
Based on the Price/Earnings ratio, BIM is valued a bit cheaper than the industry average as 67.24% of the companies are valued more expensively.
BIM's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.15.
Based on the Price/Forward Earnings ratio of 25.32, the valuation of BIM can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BIM is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.60, BIM is valued at the same level.
Industry RankSector Rank
PE 30.41
Fwd PE 25.32
BIM.PA Price Earnings VS Forward Price EarningsBIM.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BIM is valued a bit cheaper than the industry average as 68.97% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, BIM is valued a bit cheaper than the industry average as 63.79% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 43.22
EV/EBITDA 15.68
BIM.PA Per share dataBIM.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of BIM may justify a higher PE ratio.
BIM's earnings are expected to grow with 15.21% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.51
PEG (5Y)2.79
EPS Next 2Y16.12%
EPS Next 3Y15.21%

4

5. Dividend

5.1 Amount

With a yearly dividend of 0.75%, BIM is not a good candidate for dividend investing.
BIM's Dividend Yield is a higher than the industry average which is at 2.07.
With a Dividend Yield of 0.75, BIM pays less dividend than the S&P500 average, which is at 2.42.
Industry RankSector Rank
Dividend Yield 0.75%

5.2 History

On average, the dividend of BIM grows each year by 19.40%, which is quite nice.
Dividend Growth(5Y)19.4%
Div Incr Years1
Div Non Decr Years7
BIM.PA Yearly Dividends per shareBIM.PA Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

BIM pays out 23.18% of its income as dividend. This is a sustainable payout ratio.
BIM's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP23.18%
EPS Next 2Y16.12%
EPS Next 3Y15.21%
BIM.PA Yearly Income VS Free CF VS DividendBIM.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
BIM.PA Dividend Payout.BIM.PA Dividend Payout, showing the Payout Ratio.BIM.PA Dividend Payout.PayoutRetained Earnings

BIOMERIEUX

EPA:BIM (6/30/2025, 7:00:00 PM)

117.4

-1.6 (-1.34%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-15 2025-05-15
Earnings (Next)N/A N/A
Inst Owners20.89%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap13.90B
Analysts75.29
Price Target127.5 (8.6%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.75%
Yearly Dividend0.85
Dividend Growth(5Y)19.4%
DP23.18%
Div Incr Years1
Div Non Decr Years7
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.57%
PT rev (3m)-1.57%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0.14%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.46%
Valuation
Industry RankSector Rank
PE 30.41
Fwd PE 25.32
P/S 3.49
P/FCF 43.22
P/OCF 20.82
P/B 3.3
P/tB 4.66
EV/EBITDA 15.68
EPS(TTM)3.86
EY3.29%
EPS(NY)4.64
Fwd EY3.95%
FCF(TTM)2.72
FCFY2.31%
OCF(TTM)5.64
OCFY4.8%
SpS33.63
BVpS35.53
TBVpS25.2
PEG (NY)1.51
PEG (5Y)2.79
Profitability
Industry RankSector Rank
ROA 7.49%
ROE 10.28%
ROCE 12.7%
ROIC 9.33%
ROICexc 9.83%
ROICexgc 13.6%
OM 14.79%
PM (TTM) 10.86%
GM 55.66%
FCFM 8.08%
ROA(3y)7.67%
ROA(5y)9.27%
ROE(3y)10.79%
ROE(5y)13.66%
ROIC(3y)10.05%
ROIC(5y)11.9%
ROICexc(3y)11.26%
ROICexc(5y)13.92%
ROICexgc(3y)17.24%
ROICexgc(5y)22.12%
ROCE(3y)13.71%
ROCE(5y)16.2%
ROICexcg growth 3Y-22.62%
ROICexcg growth 5Y-8.16%
ROICexc growth 3Y-19.11%
ROICexc growth 5Y-1.66%
OM growth 3Y-12.86%
OM growth 5Y2.09%
PM growth 3Y-15.19%
PM growth 5Y1.26%
GM growth 3Y-2.07%
GM growth 5Y0.3%
F-Score7
Asset Turnover0.69
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 1.53
Debt/EBITDA 0.39
Cap/Depr 106.34%
Cap/Sales 8.69%
Interest Coverage 250
Cash Conversion 73.01%
Profit Quality 74.39%
Current Ratio 2.2
Quick Ratio 1.29
Altman-Z 6.8
F-Score7
WACC7.75%
ROIC/WACC1.2
Cap/Depr(3y)244.38%
Cap/Depr(5y)271.63%
Cap/Sales(3y)8.63%
Cap/Sales(5y)8.67%
Profit Quality(3y)48.66%
Profit Quality(5y)62.08%
High Growth Momentum
Growth
EPS 1Y (TTM)21.01%
EPS 3Y-8.75%
EPS 5Y10.91%
EPS Q2Q%10.71%
EPS Next Y20.14%
EPS Next 2Y16.12%
EPS Next 3Y15.21%
EPS Next 5Y13.37%
Revenue 1Y (TTM)8.31%
Revenue growth 3Y5.64%
Revenue growth 5Y8.27%
Sales Q2Q%9.1%
Revenue Next Year7.29%
Revenue Next 2Y7.04%
Revenue Next 3Y7.59%
Revenue Next 5Y6.35%
EBIT growth 1Y34.12%
EBIT growth 3Y-7.95%
EBIT growth 5Y10.54%
EBIT Next Year61.98%
EBIT Next 3Y26.54%
EBIT Next 5Y19.07%
FCF growth 1Y200.19%
FCF growth 3Y-15.59%
FCF growth 5Y18.88%
OCF growth 1Y49.82%
OCF growth 3Y-6.82%
OCF growth 5Y10.35%